Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma

Ovarian carcinosarcoma (OCS) is a rare entity with a poor prognosis and without evidence-based therapy. Here, we report the case of a 55-year-old woman with a germline BRCA1 mutation and a stage IV OCS who was proposed olaparib maintenance therapy after three platinum-based chemotherapies in relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Magalhães, Denise, Bartosch, Carla, Abreu, Miguel H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357426/
https://www.ncbi.nlm.nih.gov/pubmed/35949745
http://dx.doi.org/10.7759/cureus.26662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357426/
https://www.ncbi.nlm.nih.gov/pubmed/35949745
http://dx.doi.org/10.7759/cureus.26662

Ejemplares similares